Novikov A I, Ermolenko A E, Ermakova I P, Baeva L B, Levitskiĭ E R
Ter Arkh. 1989;61(6):105-9.
During osteomalacia in patients with terminal renal failure, the coefficient of diphosphonate elimination from the blood bed (K1) was less than 0.1 min-1, which was determined by the rise of the concentration of uremic toxins, inhibiting interaction of the radiopharmaceutical with the bone, in the patients' tissues. Dynamic scintigraphy permits one to study the pharmacokinetics of diphosphonate in every patient and thus can be used for differential diagnosis between osteomalacia and other forms of renal osteodystrophy.
在终末期肾衰竭患者发生骨软化症期间,双膦酸盐从血床的消除系数(K1)小于0.1分钟-1,这是由患者组织中尿毒症毒素浓度升高所决定的,尿毒症毒素抑制了放射性药物与骨骼的相互作用。动态闪烁扫描术可用于研究每位患者体内双膦酸盐的药代动力学,因此可用于骨软化症与其他形式肾性骨营养不良的鉴别诊断。